רפמיון 1 מ"ג

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

SIROLIMUS 1.00 MG

Pieejams no:

NEOPHARM LTD

ATĶ kods:

L04AA10

Zāļu forma:

COATED TABLETS

Ievadīšanas:

PER OS

Ražojis:

PFIZER IRELAND PHARMACEUTICALS

Ārstniecības grupa:

SIROLIMUS

Ārstēšanas norādes:

Rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. It is recommended that Rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. Rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.

Autorizācija datums:

2009-10-01